PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
70.66
+0.76 (1.09%)
At close: Feb 20, 2026, 4:00 PM EST
70.65
-0.01 (-0.01%)
After-hours: Feb 20, 2026, 6:12 PM EST
PTC Therapeutics Employees
PTC Therapeutics had 939 employees as of December 31, 2024. The number of employees decreased by 116 or -11.00% compared to the previous year.
Employees
939
Change (1Y)
-116
Growth (1Y)
-11.00%
Revenue / Employee
$1,843,083
Profits / Employee
$726,990
Market Cap
5.85B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 939 | -116 | -11.00% | 939 | 0 |
| Dec 31, 2023 | 1,055 | -355 | -25.18% | 988 | 67 |
| Dec 31, 2022 | 1,410 | 233 | 19.80% | 1,402 | 8 |
| Dec 31, 2021 | 1,177 | 210 | 21.72% | 1,167 | 10 |
| Dec 31, 2020 | 967 | 206 | 27.07% | 959 | 8 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,769 |
| CRISPR Therapeutics AG | 393 |
| Immunovant | 362 |
| Mirum Pharmaceuticals | 355 |
| Rhythm Pharmaceuticals | 283 |
| Cogent Biosciences | 258 |
| Kymera Therapeutics | 225 |
| Protagonist Therapeutics | 128 |
PTCT News
- 11 hours ago - PTC Therapeutics, Inc. (PTCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - PRNewsWire
- 8 days ago - PTC Therapeutics Provides Regulatory Update on Translarna™ - PRNewsWire
- 15 days ago - PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 - PRNewsWire
- 5 weeks ago - PTC Therapeutics, Inc. (PTCT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference - PRNewsWire
- 6 weeks ago - PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - PTC Therapeutics Announces Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU) in Japan - PRNewsWire